Decoy Therapeutics (DCOY) Shares Outstanding (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Shares Outstanding (Entity) of $531968.0 for Q1 2026, up 5654.74% year-over-year from $9244.0 in Q1 2025, and up 448.61% quarter-over-quarter from $96967.0 in Q4 2025.
Decoy Therapeutics (DCOY) Shares Outstanding (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Shares Outstanding (Entity) for 13 consecutive years, with $531968.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 5654.74% year-over-year to $531968.0; the TTM figure through Mar 2026 stood at $531968.0 (up 5654.74% YoY), while the FY2025 annual figure was $96967.0, up 1713.82% from the prior year.
- Shares Outstanding (Entity) grew to $531968.0 in Q1 2026 per DCOY's latest filing, from $96967.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $531968.0 in Q1 2026 and bottomed at $1297.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $42624.9 across 5 years, with a median of $2996.0 in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) gained 20.65% — and 2026, when it surged 5654.74%.
- Decoy Therapeutics' Shares Outstanding (Entity) stood at $1567.0 in 2022, then jumped by 44.67% to $2267.0 in 2023, then surged by 135.82% to $5346.0 in 2024, then surged by 1713.82% to $96967.0 in 2025, then jumped by 448.61% to $531968.0 in 2026.
- Business Quant data shows DCOY's Shares Outstanding (Entity) at $531968.0 in Q1 2026, $96967.0 in Q4 2025, and $40132.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | 531,968.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 531,968.00 |
| Mar 31, 2026 | 531,968.00 |
| Dec 31, 2025 | 96,967.00 |
| Sep 30, 2025 | 40,132.00 |
| Jun 30, 2025 | 11,794.00 |
| Mar 31, 2025 | 9,244.00 |
| Dec 31, 2024 | 5,346.00 |
| Sep 30, 2024 | 7,122.00 |
| Jun 30, 2024 | 3,336.00 |
| Mar 31, 2024 | 2,913.00 |
| Dec 31, 2023 | 2,267.00 |
| Sep 30, 2023 | 2,607.00 |
| Jun 30, 2023 | 1,881.00 |
| Mar 31, 2023 | 1,661.00 |
| Dec 31, 2022 | 1,475.00 |
| Sep 30, 2022 | 1,561.00 |
| Jun 30, 2022 | 1,487.00 |
| Mar 31, 2022 | 1,285.00 |
| Dec 31, 2021 | 1,149.00 |
| Sep 30, 2021 | 1,245.00 |